GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,000 | -66.7% | 108 | -58.6% | 0.00% | – |
Q1 2022 | $9,000 | -71.9% | 261 | -76.4% | 0.00% | – |
Q4 2021 | $32,000 | +28.0% | 1,106 | +15.0% | 0.00% | – |
Q3 2021 | $25,000 | -16.7% | 962 | +11.1% | 0.00% | – |
Q2 2021 | $30,000 | -16.7% | 866 | -2.0% | 0.00% | – |
Q1 2021 | $36,000 | +227.3% | 884 | +233.6% | 0.00% | – |
Q4 2020 | $11,000 | -21.4% | 265 | +6.0% | 0.00% | – |
Q3 2020 | $14,000 | -22.2% | 250 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | -53.8% | 250 | -68.9% | 0.00% | -100.0% |
Q3 2019 | $39,000 | -7.1% | 805 | +0.8% | 0.00% | -50.0% |
Q2 2019 | $42,000 | – | 799 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
Grace Capital | 312,514 | $11,876,000 | 4.65% |
NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |